Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations

PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 27, 2022

Primary Completion Date

July 31, 2025

Study Completion Date

September 30, 2025

Conditions
Tympanic Membrane Perforation
Interventions
DRUG

FGF-2

The FGF-2 method of use comprises a pledget of gelatin sponge, with human fibroblast growth factor-2 (FGF-2) added to the pledget just before topical application to the tympanic membrane, and the use of fibrin glue used for applications in ear surgery. The concentration of the FGF-2 solution will be 100μg of FGF-2 per 1 mL with an estimated dose of about 20 μg in 0.2ml. Fibrin glue will be applied to secure gelatin sponge after placement according to the size of the membrane perforation. Application of the study treatment will occur at Visit 1 and may be repeated at each follow up visit as needed for a maximum of three treatments in the Randomized Treatment Phase (Visit 1, Visit 2, and Visit 3).

DRUG

Placebo

FGF-2 will be replaced with sterile water to saturate a pledget of gelatin sponge. The method will be otherwise identical to the FGF-2 intervention.

Trial Locations (1)

10016

NYU Langone Health, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER